glp 1 and gip Science Behind Glucagon Receptor Agonists for Obesity Research | News & Announcements What Is GIP? The Metabolic

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

Weight Support*

This analysis was part of the IMI-Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (IMI-SOPHIA) project

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task

Observational studies in autoimmune rheumatic diseases (ARDs) such as rheumatoid arthritis and systemic lupus erythematosus indicate